Chloranthalactone BCAS# 66395-03-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 66395-03-7 | SDF | Download SDF |
| PubChem ID | 15767607 | Appearance | Powder |
| Formula | C15H16O3 | M.Wt | 244.29 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC1=C2CC3C(=C)C4CC4C3(C5C2(O5)OC1=O)C | ||
| Standard InChIKey | ZKAVFYQAEVFXTE-NRLMIDHWSA-N | ||
| Standard InChI | InChI=1S/C15H16O3/c1-6-8-4-11(8)14(3)9(6)5-10-7(2)12(16)17-15(10)13(14)18-15/h8-9,11,13H,1,4-5H2,2-3H3/t8-,9+,11-,13+,14-,15-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Chloranthalactone B has anti-inflammatory activity, it inhibits the production of inflammatory mediators by inhibiting the AP-1 and p38 MAPK pathways. |
| Targets | TNF-α | IL Receptor | TNF-α | COX | NOS | p38MAPK | ERK | JNK | AP-1 |
Chloranthalactone B Dilution Calculator
Chloranthalactone B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.0935 mL | 20.4675 mL | 40.935 mL | 81.8699 mL | 102.3374 mL |
| 5 mM | 0.8187 mL | 4.0935 mL | 8.187 mL | 16.374 mL | 20.4675 mL |
| 10 mM | 0.4093 mL | 2.0467 mL | 4.0935 mL | 8.187 mL | 10.2337 mL |
| 50 mM | 0.0819 mL | 0.4093 mL | 0.8187 mL | 1.6374 mL | 2.0467 mL |
| 100 mM | 0.0409 mL | 0.2047 mL | 0.4093 mL | 0.8187 mL | 1.0234 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Chloranthalactone A
Catalog No.:BCN8022
CAS No.:66395-02-6
- (+)-Apogossypol
Catalog No.:BCC5585
CAS No.:66389-74-0
- Methylsyringol
Catalog No.:BCN3535
CAS No.:6638-05-7
- TGX-221
Catalog No.:BCC1244
CAS No.:663619-89-4
- Ranitidine Hydrochloride
Catalog No.:BCC4533
CAS No.:66357-59-3
- Ranitidine
Catalog No.:BCC9134
CAS No.:66357-35-5
- 5'-Deoxy-5-fluorocytidine
Catalog No.:BCC8746
CAS No.:66335-38-4
- Dihydroguaiaretic acid
Catalog No.:BCN4212
CAS No.:66322-34-7
- ML 171
Catalog No.:BCC6252
CAS No.:6631-94-3
- 3H-1,2-Benzodithiol-3-one-1,1-dioxide
Catalog No.:BCC8633
CAS No.:66304-01-6
- Pregomisin
Catalog No.:BCN7000
CAS No.:66280-26-0
- Gomisin J
Catalog No.:BCN2270
CAS No.:66280-25-9
- 5alpha-Hydroxychloranthalactone A
Catalog No.:BCN7469
CAS No.:66395-04-8
- Pamoic acid disodium salt
Catalog No.:BCC7909
CAS No.:6640-22-8
- 13-Hydroxyoxyberberine
Catalog No.:BCN3355
CAS No.:66408-27-3
- 6-Amino-1,3-dimethyluracil
Catalog No.:BCC8755
CAS No.:6642-31-5
- 2-(2,4-Diaminophenoxy)ethanol dihydrochloride
Catalog No.:BCN8497
CAS No.:66422-95-5
- Kaempferol 3-O-(6''-O-acetyl)glucoside-7-O-rhamnoside
Catalog No.:BCN1385
CAS No.:66465-24-5
- H-D-Lys(Boc)-OMe.HCl
Catalog No.:BCC2990
CAS No.:66494-53-9
- JW 55
Catalog No.:BCC2453
CAS No.:664993-53-7
- Amantadine HCl
Catalog No.:BCC4465
CAS No.:665-66-7
- Bicifadine hydrochloride
Catalog No.:BCC7925
CAS No.:66504-75-4
- MSOP
Catalog No.:BCC6801
CAS No.:66515-29-5
- Benzoin isopropyl ether
Catalog No.:BCC8856
CAS No.:6652-28-4
Anti-Inflammatory Effects of Chloranthalactone B in LPS-Stimulated RAW264.7 Cells.[Pubmed:27879664]
Int J Mol Sci. 2016 Nov 22;17(11). pii: ijms17111938.
Chloranthalactone B (CTB), a lindenane-type sesquiterpenoid, was obtained from the Chinese medicinal herb Sarcandra glabra, which is frequently used as a remedy for inflammatory diseases. However, the anti-inflammatory mechanisms of CTB have not been fully elucidated. In this study, we investigated the molecular mechanisms underlying these effects in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. CTB strongly inhibited the production of nitric oxide and pro-inflammatory mediators such as prostaglandin E(2), tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 in RAW264.7 cells stimulated with LPS. A reverse-transcription polymerase chain reaction assay and Western blot further confirmed that CTB inhibited the expression of inducible nitric oxide synthase, cyclooxygenase-2, TNF-alpha, and IL-1beta at the transcriptional level, and decreased the luciferase activities of activator protein (AP)-1 reporter promoters. These data suggest that inhibition occurred at the transcriptional level. In addition, CTB blocked the activation of p38 mitogen-activated protein kinase (MAPK) but not c-Jun N-terminal kinase or extracellular signal-regulated kinase 1/2. Furthermore, CTB suppressed the phosphorylation of MKK3/6 by targeting the binding sites via formation of hydrogen bonds. Our findings clearly show that CTB inhibits the production of inflammatory mediators by inhibiting the AP-1 and p38 MAPK pathways. Therefore, CTB could potentially be used as an anti-inflammatory agent.
Three novel sesquiterpene glycosides of Sarcandra glabra.[Pubmed:19336941]
Chem Pharm Bull (Tokyo). 2009 Apr;57(4):418-20.
Three new sesquiterpene glycosides, 8 beta,9 beta-epoxy-4 alpha-hydroxy-5 alpha H-lindan-7(11)-en-8 alpha,12-olide-15-O-beta-D-glucopyranoside (1, sarcaglaboside F), 4 alpha-hydroxy-5 alpha,8 beta H-lindan-7(11)-en-8 alpha,12-olide-15-O-beta-D-glucopyranoside (2, sarcaglaboside G), 4 alpha-hydroxy-5 alpha,8 beta H-eudesman-7(11)-en-8 alpha,12-olide-15-O-beta-D-glucopyranoside (3, sarcaglaboside H), together with five known compounds, chloranoside A (4), sarcaglaboside C (5), dihydrovomifoliol-O-beta-D-glucopyranoside (6), 9-hydroxy-heterogorgiolide (7) and Chloranthalactone B (8), were isolated from Sarcandra glabra THUMB. NAKAI. The structures and relative configurations of three new compounds were determined on the basis of their spectroscopic data and chemical evidence.
